T44.8X3 Category · further specificity required Poisoning by centrally-acting and adrenergic-neuron-blocking agents, assault
ICD-10-CM T44.8X3 identifies “Poisoning by centrally-acting and adrenergic-neuron-blocking agents, assault” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 19: Injury, poisoning and certain other consequences of external causes
Code-level instructions
No additional notes.
Inherited instructions
Chapters 19 · Injury, poisoning and certain other consequences of external causes (S00-T88)
Excludes 22
- birth trauma (P10-P15)
- obstetric trauma (O70-O71)
Use additional code1
code to identify any retained foreign body, if applicable (Z18.-)
Note2
- Use secondary code(s) from Chapter 20, External causes of morbidity, to indicate cause of injury. Codes within the T section that include the external cause do not require an additional external cause code
- The chapter uses the S-section for coding different types of injuries related to single body regions and the T-section to cover injuries to unspecified body regions as well as poisoning and certain other consequences of external causes.
T36-T50 · Poisoning by, adverse effects of and underdosing of drugs, medicaments and biological substances (T36-T50)
Includes4
- adverse effect of correct substance properly administered
- poisoning by overdose of substance
- poisoning by wrong substance given or taken in error
- underdosing by (inadvertently) (deliberately) taking less substance than prescribed or instructed
Excludes 11
toxic reaction to local anesthesia in pregnancy (O29.3-)
Excludes 25
Code first7
Use additional code4
Note1
The drug giving rise to the adverse effect should be identified by use of codes from categories T36-T50 with fifth or sixth character 5.
T44 · Poisoning by, adverse effect of and underdosing of drugs primarily affecting the autonomic nervous system
Seventh character1
The appropriate 7th character is to be added to each code from category T44
A — initial encounter
D — subsequent encounter
S — sequela
T44.8 · Poisoning by, adverse effect of and underdosing of centrally-acting and adrenergic-neuron- blocking agents
More specific codes
T44.8X3APoisoning by centrally-acting and adrenergic-neuron-blocking agents, assault, initial encounterBillable / specificT44.8X3DPoisoning by centrally-acting and adrenergic-neuron-blocking agents, assault, subsequent encounterBillable / specificT44.8X3SPoisoning by centrally-acting and adrenergic-neuron-blocking agents, assault, sequelaBillable / specificOfficial index references
Official index references (7)
Adrenergic NEC (1)
- Adrenergic NEC › blocking agent NECDrugs and chemicals
Alfuzosin(hydrochloride) (1)
- Alfuzosin(hydrochloride)Drugs and chemicals
Antiadrenergic NEC (1)
- Antiadrenergic NECDrugs and chemicals
Labetalol (1)
- LabetalolDrugs and chemicals
Medroxalol (1)
- MedroxalolDrugs and chemicals
Sympatholytic NEC (2)
- Sympatholytic NECDrugs and chemicals
- Sympatholytic NEC › haloalkylamineDrugs and chemicals
History
Code history
Latest recorded change · FY2025 · 04-01
Effective from
- Inherited rules changed
Poisoning by centrally-acting and adrenergic-neuron-blocking agents, assault
Category — select a more specific code
CDC/NCHS · FY2025 · 04-01All editions (19)
| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | No tabular change |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | Inherited rules changed |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | Inherited rules changed |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | Inherited rules changed |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | Inherited rules changed |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Explore the more specific codes in this category. Reference checks do not establish clinical appropriateness or guarantee reimbursement.